Surveillance of Swine Coronaviruses in Hungarian Herds with a Newly Established Pan-Coronavirus RT-PCR System

✅ 全文

匈牙利猪群中猪冠状病毒的监测及新建立的泛冠状病毒RT-PCR检测系统的应用

作者 Dóra Máté; Renáta Varga-Kugler; Eszter Kaszab; Henrik Fülöp Károlyi; Tamás Görföl; Gábor Kemenesi; Barbara Igriczi; Gyula Balka; Marianna Domán; Ádám Bálint; Zoltán Zádori; Enikő Fehér 期刊 Animals 发表日期 2026 卷/期/页码 Vol. 16(3) ISSN 2076-2615 DOI 10.3390/ani16030358 类型 原创研究 (Original Research)

📄 中文摘要 Chinese Abstract

中文
冠状病毒(CoVs)是高度多样且快速进化的RNA病毒,对人类和动物健康具有重大影响。其重组和突变倾向使其能够跨物种传播并引发新型病原体,SARS-CoV-2大流行即凸显了这一点。尽管目前已存在针对已知致病性冠状病毒的诊断工具,但检测新发或意外变异株需要广谱方法。本研究旨在开发一种泛冠状病毒RT-PCR系统,能够识别广泛的哺乳动物和禽类冠状病毒,以支持监测工作并增强对新兴病毒威胁的防范能力。

📋 英文结构化总结 English Structured Summary

全文整理

EN

Background:

Coronaviruses (CoVs) are highly diverse, rapidly evolving RNA viruses with significant implications for human and animal health. Their propensity for recombination and mutation enables cross-species transmission and emergence of novel pathogens, as highlighted by the SARS-CoV-2 pandemic. While diagnostic tools exist for known pathogenic CoVs, detecting new or unexpected variants requires broad-spectrum methods. This study aimed to develop a pan-coronavirus RT-PCR system capable of identifying a wide range of mammalian and avian CoVs, supporting surveillance efforts and enhancing preparedness for emerging viral threats.

Methods:

A semi-nested RT-PCR assay targeting the RNA-dependent RNA polymerase (RdRp) gene was developed using degenerate primers. Optimization included testing one-step and two-step RT-PCR protocols with three reverse transcriptases (SuperScript IV, RevertAid, and QIAGEN OneStep), random hexamer vs. virus-specific priming, and standard versus touchdown cycling profiles. In vitro transcribed RNAs from ten CoVs—SARS-CoV, SARS-CoV-2, NL-63, OC43, feline CoV, PEDV, TGEV, canine CoV, bat CoV, and infectious bronchitis virus—were used as templates instead of DNA standards to better reflect real-world RNA virus detection. The assay was applied to 121 pooled swine oral fluid, nasal swab, and processing fluid samples collected from clinically healthy Hungarian pig herds between 2020 and 2022.

Results:

The optimized two-step RT-PCR using SuperScript IV with random hexamer priming and touchdown cycling achieved a limit of detection (LOD) of 5–50 copies/reaction across all ten tested CoVs, outperforming previously published primer sets in both sensitivity and specificity. RNase inhibitor use significantly improved RNA stability and detection sensitivity. When applied to field samples, CoV sequences were identified in 24 of 121 pools (19.8%). Sanger sequencing revealed 12 samples positive for porcine respiratory coronavirus (PRCV)/transmissible gastroenteritis virus (TGEV) and 12 for porcine hemagglutinating encephalomyelitis virus (PHEV), with co-circulation observed at two farms. No PEDV was detected.

Data Summary:

The novel assay detected CoVs in 24/121 (19.8%) pooled swine samples. Twelve sequences showed 99.64% nucleotide identity to PRCV, and twelve showed 99.10% identity to PHEV in GenBank. Positive samples originated from five Hungarian farms, with two farms harboring both viruses. The LOD ranged from 5 to 50 RNA copies/reaction depending on the virus and RT enzyme used, with SuperScript IV yielding the lowest LODs. In comparison, a previously published pan-CoV PCR (C1 primer set) detected only 8 of the 24 positive samples.

Conclusions:

The newly established pan-coronavirus RT-PCR system demonstrates superior sensitivity and broader detection capability compared to earlier assays, effectively identifying diverse mammalian and avian CoVs. Its performance is highly dependent on RT enzyme selection and RNase inhibitor usage. The study confirms the silent circulation of PRCV/TGEV and PHEV in clinically healthy swine herds in Hungary, underscoring the value of broad-spectrum surveillance tools in monitoring CoV diversity and potential emergence.

Practical Significance:

This pan-CoV RT-PCR system is primarily suited for research and surveillance purposes, enabling early detection of known and novel coronaviruses in animal populations. It can support One Health initiatives by identifying spillover risks and informing preparedness strategies for emerging zoonotic pathogens, particularly in livestock interfaces where cross-species transmission may occur.

📋 中文结构化总结 Chinese Structured Summary

中文

背景:

冠状病毒(CoVs)是高度多样且快速进化的RNA病毒,对人类和动物健康具有重大影响。其重组和突变倾向使其能够跨物种传播并引发新型病原体,SARS-CoV-2大流行即凸显了这一点。尽管目前已存在针对已知致病性冠状病毒的诊断工具,但检测新发或意外变异株需要广谱方法。本研究旨在开发一种泛冠状病毒RT-PCR系统,能够识别广泛的哺乳动物和禽类冠状病毒,以支持监测工作并增强对新兴病毒威胁的防范能力。

方法:

开发了一种靶向RNA依赖性RNA聚合酶(RdRp)基因的半巢式RT-PCR检测方法,使用简并引物。优化内容包括测试一步法和两步法RT-PCR方案,使用三种逆转录酶(SuperScript IV、RevertAID和QIAGEN OneStep)、随机六聚体引物与病毒特异性引物对比,以及标准循环与降落循环条件。使用十种冠状病毒的体外转录RNA作为模板而非DNA标准品,以更好地反映真实世界中的RNA病毒检测情况,这十种冠状病毒包括SARS-CoV、SARS-CoV-2、NL-63、OC43、猫冠状病毒、PEDV、TGEV、犬冠状病毒、蝙蝠冠状病毒和传染性支气管炎病毒。将该检测方法应用于2020年至2022年间从临床健康的匈牙利猪群中采集的121份混合猪口腔液、鼻拭子和处理液样本。

结果:

优化后的两步法RT-PCR采用SuperScript IV逆转录酶、随机六聚体引物和降落循环条件,在全部十种测试冠状病毒中实现了5–50拷贝/反应的检测限(LOD),在灵敏度和特异性方面均优于此前已发表的引物组。使用RNase抑制剂显著提高了RNA稳定性和检测灵敏度。在应用于田间样本时,在121份混合样本中的24份(19.8%)中检测到冠状病毒序列。Sanger测序结果显示,12份样本为猪呼吸性冠状病毒(PRCV)/猪传染性胃肠炎病毒(TGEV)阳性,12份为猪血凝性脑脊髓炎病毒(PHEV)阳性,在两个农场观察到两种病毒共循环。未检测到PEDV。

数据摘要:

新开发的检测方法在121份混合猪样本中的24份(19.8%)中检测到冠状病毒。其中12份序列与GenBank中PRCV的核苷酸同源性为99.64%,12份与PHEV的同源性为99.10%。阳性样本来自五个匈牙利农场,其中两个农场同时存在两种病毒。检测限根据所用病毒和逆转录酶的不同,范围为5至50 RNA拷贝/反应,其中SuperScript IV产生的LOD最低。相比之下,此前发表的泛冠状病毒PCR(C1引物组)仅检测到24份阳性样本中的8份。

结论:

新建立的泛冠状病毒RT-PCR系统相较于早期检测方法展现出更优越的灵敏度和更广的检测能力,可有效识别多种哺乳动物和禽类冠状病毒。其性能高度依赖于逆转录酶的选择和RNase抑制剂的使用。本研究证实了PRCV/TGEV和PHEV在匈牙利临床健康猪群中的无症状循环,凸显了广谱监测工具在监测冠状病毒多样性及潜在出现中的价值。

实际意义:

该泛冠状病毒RT-PCR系统主要适用于研究和监测目的,能够在动物群体中早期检测已知和新型冠状病毒。它可通过识别溢出风险和支持新发人畜共患病原体的防范策略来支持"同一健康"倡议,特别是在可能发生跨物种传播的畜牧生产环节中。

📖 英文全文 English Full Text

EN

2763 animals Animals : an Open Access Journal from MDPI Animals (Basel) Multidisciplinary Digital Publishing Institute (MDPI) PMC12896397 12896397 12896397 41681341 10.3390/ani16030358 Surveillance of Swine Coronaviruses in Hungarian Herds with a Newly Established Pan-Coronavirus RT-PCR System Máté Dóra Validation, Investigation, Writing – original draft, Visualization, Project administration 1 Varga-Kugler Renáta Methodology, Investigation, Project administration 2 Kaszab Eszter Methodology, Validation, Investigation, Data curation, Writing – original draft, Writing – review & editing 1 3 4 * Károlyi Henrik Fülöp Investigation 5 Görföl Tamás Resources, Funding acquisition 5 Kemenesi Gábor Resources, Funding acquisition 5 6 Igriczi Barbara Methodology, Investigation, Writing – original draft, Project administration 3 7 Balka Gyula Methodology, Resources, Writing – original draft, Funding acquisition 3 7 Domán Marianna Investigation 8 Bálint Ádám Methodology, Investigation, Resources 9 Zádori Zoltán Resources, Writing – original draft 8 Fehér Enikő Conceptualization, Methodology, Investigation, Resources, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration, Funding acquisition 1 3 5 Marsilio Fulvio Academic Editor 1 Department of Microbiology and Infectious Diseases, University of Veterinary Medicine Budapest, Hungária krt. 23-25, H-1143 Budapest, Hungary 2 Ceva-Phylaxia Ltd., Szállás utca 5, H-1107 Budapest, Hungary 3 National Laboratory for Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, István utca 2, H-1078 Budapest, Hungary 4 Department of Bioinformatics, One Health Institute, Faculty of Health Sciences, University of Debrecen, Nagyerdei krt. 98, H-4032 Debrecen, Hungary 5 National Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Ifjúság útja 20, H-7624 Pécs, Hungary 6 Institute of Biology, Faculty of Sciences, University of Pécs, Ifjúság útja 6, H-7624 Pécs, Hungary 7 Department of Pathology, University of Veterinary Medicine Budapest, István utca 2, H-1078 Budapest, Hungary 8 HUN-REN Veterinary Medical Research Institute, Hungária krt. 21, H-1143 Budapest, Hungary 9 Vetcontrol Ltd., Déli-Bekötő út 8, H-1211 Budapest, Hungary * Correspondence: kaszab.eszter@univet.hu 23 1 2026 16 3 358 358 13 2 2026 © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license . Simple Summary Due to the SARS-CoV-2 pandemic, we have become familiar with coronaviruses. These viruses have a highly diverse, rapidly changing genome that aids in widespread distribution and transmission to novel hosts. Although several simple, virus-specific tests are available to detect the most important pathogenic coronaviruses, the identification of new viruses and variants requires different approaches. In our study, we developed a broad-spectrum detection system for coronaviruses. The sensitivity of the assay was measured using ten different coronaviruses that infect humans and animals and was compared with other systems. Application of the novel method demonstrated the circulation of coronaviruses in swine herds, as well as the suitability of the established tool for their detection. The assay described here is primarily intended for research purposes and could significantly advance our understanding of the diversity and host spectrum of coronaviruses and help us prepare for the emergence of new pathogens. Keywords: pan-coronavirus, PCR, mammalian, avian, human, swine Abstract The rapid evolution of coronaviruses (CoVs) requires researchers to develop specific yet broad-spectrum detection methods to monitor their constant genomic changes. The goal of the present study was to establish a current pan-coronavirus RT-PCR system capable of detecting a wide variety of CoVs and useful for the investigation of virus diversity and host spectrum. For optimization, one-step and two-step nested RT-PCRs with three RT enzymes were examined, amplifying a ~600 bp long product of the RNA-dependent RNA polymerase. As templates, the in vitro transcribed RNA of ten pathogenic CoVs (SARS-CoV, SARS-CoV-2, NL-63, OC43, feline CoV, porcine epidemic diarrhea virus or PEDV, transmissible gastroenteritis virus or TGEV, canine CoV, bat CoV, and infectious bronchitis virus) were applied instead of the often-used DNA standards. A limit of detection of 5–50 copies/reaction was achieved with a random hexamer-primed two-step RT-PCR and a touchdown cycling profile, representing a lower detection limit and higher specificity compared to previously published primer sets. Swine origin pooled samples ( n = 121), collected from apparently healthy herds in Hungary, were tested with the novel RT-PCR system. Sequences of porcine respiratory CoV/TGEV and porcine hemagglutinating encephalomyelitis virus were identified in 24 oral fluid and nasal swab pools, demonstrating the circulation of these viruses in this country, as well as the suitability of the new PCR for their detection. The results highlighted the importance of adequate RT enzyme selection and the use of RNase inhibitors in sample preparation and conservation. status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Received 2025 Dec 18; Revised 2026 Jan 16; Accepted 2026 Jan 20; Collection date 2026 Feb. 1. Introduction Most people associate the word coronavirus (CoV) with the disease acronym COVID-19 and the causative agent behind it, severe acute respiratory syndrome CoV-2 (SARS-CoV-2). However, CoVs of veterinary importance are also widespread. Genome and phylogenetic analyses have revealed the complex and devious evolution of CoVs. A well-known phenomenon is the propensity for recombination in cases of co-infections of multiple CoVs. Recombination and accumulation of mutations, as consequences of imprecise nucleotide incorporations driven by the RNA-dependent RNA polymerase (RdRp), allow for high adaptability, resulting in the emergence and spread of new viruses, as well as cross-species transmission. Spillover events might lead to zoonosis and implicate the possibility of reverse zoonotic infections among humans and mammals [ 1 , 2 , 3 , 4 , 5 , 6 , 7 ]. CoVs (family Coronaviridae , order Nidovirales ) are classified into the Alpha -, Beta -, Gamma -, and Deltacoronavirus genera [ 8 ]. The Alphacoronavirus and Betacoronavirus genera include mammalian- and human-associated viruses, while the Gamma - and Deltacoronavirus genera contain viruses infecting both mammals and birds [ 8 ]. The virions are enveloped and have a 25–31 kb long, positive-sense, single-stranded RNA genome. Their genomic structure is highly diverse; open reading frames (ORF) 1a and 1b of the non-structural proteins, as well as the ORFs of the nucleocapsid (N), spike (S), membrane (M), and envelope (E) proteins, are found and arranged in this order, while the number and function of the accessory protein-encoding genes vary even among strains [ 9 ]. The much-studied and common diagnostic target S protein shows high variability among species. It mediates the receptor binding, the entry of the virus into the cell, and the activation of the immune system [ 9 ]. CoVs have been blamed for diseases of various types and severity. Humans are often encountered with common cold-like conditions caused by HCoV-229E, HCoV-NL63, HCoV-OC43, or HCoV-HKU1 [ 10 ]. The most notorious, human-associated, zoonotic CoVs (SARS-CoV, SARS-CoV-2, and Middle East respiratory syndrome CoV) are responsible for systemic, even fatal, syndromes [ 10 , 11 , 12 , 13 ]. Regarding veterinary aspects of CoV infections, several economically important CoVs can be identified, including the infectious bronchitis virus (IBV), bovine CoV, feline CoV (FCoV), canine CoVs (CCoV), and swine CoVs (porcine epidemic diarrhea virus or PEDV; transmissible gastroenteritis virus or TGEV; porcine respiratory CoV or PRCV, a deletion variant of TGEV; porcine hemagglutinating encephalomyelitis virus or PHEV; swine acute diarrhea syndrome CoV; porcine delta CoV) [ 1 , 4 , 5 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ]. Due to their role in CoV evolution, monitoring bat CoVs is definitely important [ 4 , 22 ]. Early recognition of CoV infections and emerging variants has a significant impact on human and animal healthcare. However, overall detection is challenging due to their genomic diversity. In this study, we aimed to develop a universal pan-coronavirus detection system with the broadest possible specificity, primarily for researchers to reveal the diversity and genomic changes of CoV. This method has been successfully tested on human and animal CoV isolates and samples with three different RT enzymes. Field samples from swine were surveyed, and besides PRCV/TGEV, PHEV sequences could be identified. Based on the control and field sample collection, the primers described herein represented higher specificity when compared to previously published oligonucleotides. 2. Materials and Methods 2.1. Samples Clinical samples of animal origin (bat, swine, canine, poultry) and coronavirus isolates (FCoV, NL-63, OC43) were provided by the Department of Pathology, University of Veterinary Medicine, Budapest, Hungary; the HUN-REN Veterinary Medical Research Institute, Budapest, Hungary; and the National Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Hungary. Nucleic acid was extracted with the NucleoSpin RNA Virus kit (Macherey-Nagel, Düren, Germany) according to the manufacturer’s instructions. RNAs of SARS-CoV and SARS-CoV-2 variants “alpha”, “delta”, and “omicron” were extracted and supplied by the National Laboratory of Virology, Szentágothai Research Centre, University of Pécs, Hungary, in accordance with the appropriate biosafety requirements. Altogether, 121 pooled oral fluid ( n = 84, one sampling rope per pen), nasal swab ( n = 34, pooled samples of 4–5 swine per sample, from 162 animals), and processing fluid ( n = 3, retrieved during castration) specimens of clinically healthy swine were tested for CoVs. These were collected between 2020 and 2022 from pig farms in Hungary from 3–7-day-old piglets (processing fluid), 2–10-week-old (nasal swab) and 8–12-week-old (oral fluid) pigs, and 17–30-week-old fatteners (oral fluid) that did not show clinical signs of disease during the sampling period [ 23 , 24 ]. In terms of their type, these were farrow-to-finish farms for industrial raising with variations in genetics and sow herd size (520–2200 sows) [ 23 , 24 ]. Coronavirus vaccines were not applied to the herds where data were available. Nucleic acid was extracted with the QIAmp cador Pathogen Mini Kit (QIAGEN, Hilden, Germany) using the QIAcube instrument according to the instructions. 2.2. RT and PCR For the primary testing of oligonucleotides, the RT step was carried out with SuperScript IV Reverse Transcriptase (SSIV, Thermo Scientific, Waltham, MA, USA). As a first step, the following components were combined and incubated at 65 °C for 5 min and then put on ice: 7.5 µL of nuclease-free water, 1 µL of 50 µM random hexamer primer mix, 1 µL of 10 mM dNTP mix, and 5 µL of RNA template. As a second step, 4 µL of 5× SSIV Buffer, 0.5 µL of RiboLock RNase Inhibitor (Thermo Scientific, Waltham, MA, USA), and 1 µL of SSIV enzyme were added to reach the final volume of 20 µL, and the mixture was incubated at 23 °C for 10 min, 55 °C for 10 min, and 80 °C for 10 min. SSIV was applied for RT with variable CoV-specific reverse primer sets as well, using 1 µL of 10 µM primer mixtures ( Table 1 ) with an incubation protocol of 55 °C for 10 min and 80 °C for 10 min. Table 1 The oligonucleotide sequences described in this study.

Primer Set Primer Sequence 5′–3′ Semi-nested PCR Fw-mix GGNTGGGAYTAYCCNAAATGTGA GGNTGGGAYTAYCCNAAGTGCGA GGNTGGGAYTAYCCNAAGTGTGA Rev-mix1 ARNGGRTANGCRTCWATTGC ARNGGRTANGCRTCWATGGC ARNGGRTANGCRTCWATAGC Rev-mix2 TGYTGNGARCARAAYTCRTGNGGTCC TGYTGNGARCARAAYTCRTGNGGACC TGYTGNGARCARAAYTCRTGNGGGCC TGYTGNGARCARAAYTCRTGNGGCCC in vitro transcription Fw-T7-mix TAATACGACTCACTATAGGGGGNTGGGAYTAYCCNAAATGTGA TAATACGACTCACTATAGGGGGNTGGGAYTAYCCNAAGTGCGA TAATACGACTCACTATAGGGGGNTGGGAYTAYCCNAAGTGTGA Rev-T7-mix TCCTCCTCCTCCARNGGRTANGCRTCWATTGC TCCTCCTCCTCCARNGGRTANGCRTCWATGGC TCCTCCTCCTCCARNGGRTANGCRTCWATAGC RevertAid Reverse Transcriptase (Thermo Scientific, Waltham, MA, USA) was tested with a protocol corresponding to that described for SSIV. The mixture was incubated at 25 °C for 10 min, 50 °C for 60 min, and 70 °C for 10 min. Coronavirus sequences were obtained from GenBank and aligned for PCR primer design ( File S1 ). The coronavirus-specific nested PCRs were performed in a 25 μL volume containing 1× DreamTaq Green buffer, 200 μM of dNTP mix, 400 nM of the Fw-mix1 primer, 400 nM of the Rev-mix1/Rev-mix2 primers (for the first and second PCR of the nested protocol, respectively, Table 1 ), 0.75 U of DreamTaq DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, USA), and 2 μL of the RT reaction mixture. The normal cycling protocol consisted of an initial denaturation step at 95 °C for 5 min, 35/40 cycles (for the first and second PCR of the nested protocol, respectively) of the steps denaturation at 95 °C for 30 s, primer annealing at 53 °C for 30 s, and extension at 72 °C for 1 min, as well as a final extension step at 72 °C for 10 min. A touchdown cycling protocol was executed for the first PCR step of the nested PCRs as follows: initial denaturation step at 95 °C for 3 min; 10 cycles of denaturation at 95 °C for 30 s, primer annealing at 62–53 °C for 30 s with 1 °C decrease per cycle, and extension at 72 °C for 1 min; 30 cycles of denaturation at 95 °C for 30 s, primer annealing at 53 °C for 30 s, and extension at 72 °C for 1 min; a final extension step at 72 °C for 5 min. Following touchdown cycling, the second PCR of the nested protocol corresponded to that described above for the nested PCR. One-step RT-PCR was carried out with the QIAGEN OneStep RT-PCR Kit (QIAGEN, Hilden, Germany) in a 25 μL volume containing 1× QIAGEN One-Step RT-PCR Buffer, 400 nM of the Fw-mix primer, 600 nM of the Rev-mix1 primer ( Table 1 ), 400 μM dNTP mix, 0.6 μL RiboLock RNase Inhibitor, 1 μL OneStep Enzyme Mix, and 5 μL of the purified nucleic acid. The cycling protocol was as follows: RT-step at 50 °C for 30 min and 95 °C for 15 min; 10 cycles of denaturation at 94 °C for 20 s, primer annealing at 62–53 °C for 30 s with 1 °C decrease per cycle, and extension at 72 °C for 1 min; 30 cycles of denaturation at 95 °C for 30 s, primer annealing at 53 °C for 30 s, and extension at 72 °C for 1 min; a final extension step at 72 °C for 10 min. Following one-step RT-PCR, the second PCR of the nested protocol corresponded to that described for other PCRs using DreamTaq DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, USA). PCR products of ~600 bp in length were purified from agarose gel with the NucleoSpin Gel and PCR Clean-Up Kit (Macherey-Nagel, Düren, Germany), and Sanger sequencing was performed for sequence confirmation by a service company. The novel oligonucleotides were compared to previously published primers using nested PCR amplification set to that of those described in the referred protocol, using SSIV Reverse Transcriptase (Thermo Scientific, Waltham, MA, USA) and DreamTaq DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, USA) or QIAGEN OneStep RT-PCR Kit (QIAGEN, Hilden, Germany) and DreamTaq DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, USA) in combination. Pan-CoV PCRs were performed from 121 pooled swine samples following the RT step carried out with SSIV (Thermo Scientific, Waltham, MA, USA), as described above. The nested PCR primers developed in this study were applied according to the touchdown protocol, also detailed in Section 2.3 . 2.3. In Vitro Transcription RNA standards were generated by in vitro transcription using the TranscriptAid T7 High Yield Transcription Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. The T7 promoter sequence was incorporated into the linear DNA templates through the forward oligonucleotides Fw-T7-mix, while the reverse primers of the Rev-T7-mix contained an extension on the 5′ ends ( Table 1 ). Following transcription, the ~793 bp long RNA standards were purified with the NucleoSpin RNA Virus kit (Macherey-Nagel, Düren, Germany) and were stored at −70 °C in nuclease-free water supplemented with RiboLock RNase Inhibitor (Thermo Fisher Scientific, Waltham, MA, USA). The concentration of the RNA standards was measured with a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA), and a tenfold serial dilution of the RNAs was prepared in nuclease-free water containing RNase inhibitor. The copy number was set to 5 × 10 4 –5 × 10 0 RNA copies per PCR reaction. 2.4. Software Coronavirus reference sequences were selected based on the literature and retrieved from GenBank for primer design. The nt alignments of RdRp sequences were generated with the MAFFT algorithm of Geneious Prime v.2024.0.3 (Biomatters, Auckland, New Zealand). The generated sequences were checked with the Basic Local Alignment Search Tool (BLAST, online platform) [ 25 ]. Phylogenetic analyses were executed with the MEGA X software, neighbor-joining method, and p-distance model, using 1000 bootstrap replicates [ 26 ]. 3. Results As expected, based on the sequence alignment, the RdRp gene proved to be the most appropriate target for broad-spectrum PCR amplification. The primary oligonucleotide tests and in vitro transcription were executed using clinical samples and CoV isolates of human (α-CoV: NL-63; β-CoV: SARS-CoV, SARS-CoV-2 variants “alpha”, “delta”, and “omicron”, and OC43 isolates) and animal origin (α-CoV: FCoV isolated from a cat with feline infectious peritonitis, CCoV, PEDV, TGEV, and bat CoVs; γ-CoV: IBV). Unfortunately, specimens containing δ-CoV were unavailable. Where available, the oligonucleotides were tested with more than one specimen for the respective coronavirus (bat CoVs, CCoV, PEDV, TGEV, IBV, and SARS-CoV-2 variants). A large number of degenerate oligonucleotides were examined with a basic protocol involving SSIV reverse transcriptase and DreamTaq DNA polymerase. Further optimization was carried out using the most suitable forward and reverse primer mixes. RT was performed with both random hexamer and CoV-specific reverse primer sets. The annealing temperature was investigated in matrices, and the oligonucleotides tolerated a broad spectrum of temperatures. A temperature of 53 °C was selected for annealing in subsequent experiments. Finally, following random hexamer RT priming, a primer combination suitable for semi-nested PCR produced the most robust results, containing one forward and two reverse primer sets (Fw-mix, Rev-mix1, and Rev-mix2, Table 1 ). The first PCR amplified a fragment of the coronavirus RdRp that was approximately 760 bp long, while the second, nested PCR product was approximately 600 bp in length. Although the amplicons of the first PCR could be visualized on an agarose gel, the bands were less intense than those of the second, nested PCR. During the optimization of the pan-CoV semi-nested PCR with the chosen primer sets, the suitability of the previously defined factors (such as primer concentrations, annealing temperature, or the amplification cycles) was also continuously reviewed. Amplification was efficient with 30–45 cycles for the first, and 35–45 cycles for the nested PCR. While both methods were effective, random hexamers were more suitable for RT priming than Rev-mix1. To determine the limit of detection (LOD) of the RT-PCR, RNA standards were generated by in vitro transcription. After measuring the quality and quantity, tenfold serial dilutions were prepared from the RNAs, with 5 × 10 4 –5 × 10 0 RNA copies/reaction. The RNA series were investigated in triplicate, and the assay was repeated a minimum of three times. Dilutions of the in vitro transcribed RNAs were prepared both with and without RNase inhibitor. The LOD values were far better (one or two orders of magnitude) when the inhibitor enzyme was used, even though the RNAs were always freshly diluted with nuclease-free water and plastic labware. RT was performed using two RT enzymes (SSIV and RevertAid Reverse Transcriptase) and random hexamers, as well as with one-step RT-PCR (QIAGEN OneStep RT-PCR Kit) and the Rev-mix1 oligonucleotide set. The RT step was followed by the semi-nested PCR, while a single nested PCR was carried out following the one-step RT-PCR. In addition to the standard cycling protocol with annealing at 53 °C, touchdown cycling was assessed. In most cases, the lowest LOD values were obtained using the SSIV RT enzyme and random hexamers in combination with the novel primer sets and the touchdown cycling protocol in the first PCR, slightly lower than the LOD values measured for the one-step RT-PCR protocol ( Figure 1 , Table 2 ). The LODs gained by the use of the RevertAid RT enzyme were orders of magnitude higher than the results obtained by the other two RT enzymes, the SSIV and the OneStep RT-PCR enzyme ( Table 2 ). Figure 1 Agarose gel electrophoresis of products amplified by the novel coronavirus-specific broad-spectrum semi-nested RT-PCR from in vitro transcribed feline coronavirus RNA-dependent RNA polymerase fragments (six repeats from two RNA dilution series). Reverse transcription was implemented using random hexamer priming. The first PCR of the semi-nested amplification reaction was carried out with a touchdown cycling protocol. The values represent the limit of detection expressed as copies/reactions. M: DNA ladder. Table 2 Limit of detection values (copies/reaction) measured for the novel coronavirus-specific primers using variable reverse transcriptase and touchdown PCR profiles.

SuperScript IV RT QIAGEN One-Step RT-PCR RevertAid RT SARS-CoV 5 × 10 1 5 × 10 2 5 × 10 2 SARS-CoV-2 5 × 10 1 5 × 10 2 5 × 10 2 OC43 5 × 10 0 5 × 10 1 5 × 10 3 NL-63 5 × 10 1 5 × 10 2 5 × 10 2 PEDV 5 × 10 0 5 × 10 1 5 × 10 2 TGEV 5 × 10 1 5 × 10 2 5 × 10 1 CCoV 5 × 10 0 5 × 10 1 5 × 10 2 FCoV 5 × 10 1 5 × 10 1 5 × 10 1 Bat 5 × 10 1 5 × 10 2 5 × 10 1 IBV 5 × 10 0 5 × 10 2 5 × 10 3 The novel oligonucleotides were compared with two other broad-spectrum CoV-specific primer sets (C1 and C2) described earlier in relevant publications, applying the referred RT enzymes and cycling protocols, also for primers Fw-mix, Rev-mix1, and Rev-mix2. In general, the newly designed primers resulted in lower LOD values and higher specificity (the previously published primers did not present positivity with all RNA standards) and produced more intense bands in the agarose gel than the other two primer sets ( Figure 2 ). Figure 2 Agarose gel electrophoresis of products amplified by coronavirus-specific broad-spectrum oligonucleotides published previously (panel ( A ): primer set C1; panel ( B ): primer set C2) or developed in the present study. In every comparison, the amplification protocol was set to that described for reference primers C1 and C2, and it was also applied to the novel primer sets. The values represent the limit of detection expressed as copies/reactions, obtained for in vitro transcribed bat and feline coronavirus (panel ( A )), and SARS-CoV-2 (panel ( B )) RNA-dependent RNA polymerase fragments. M: DNA ladder. To evaluate its effectiveness, the PCR system developed here was used to test 121 pooled swine samples, and CoV sequences were identified in 24 (19.8%) ( Table 3 ). Although RdRp fragments of multiple coronaviruses could be amplified in the same reaction, Sanger sequencing identified one virus in each sample (GenBank acc. no. PV9488443-PV9488453 and PX677392-PX677399 ). Twelve of the sequences showed the highest identity with PRCV (99.64% nt identity), and twelve with PHEV (99.10% nt identity) sequences deposited in GenBank. Two nasal swab samples tested positive for PRCV, four for PHEV, while the other eighteen were oral fluid specimens, ten PRCV, along with eight PHEV sequences. The identified coronaviruses were found at five different settlements/farms in Hungary, with two representing both PRCV and PHEV (labeled with the letters ST and KB) ( Table 3 ). Table 3 Results of coronavirus surveillance performed with the novel oligonucleotides and protocol (this study), and a previously published (C1) pan-coronavirus-nested PCR on swine samples, representing the samples that tested positive. Sample Type Positive by Primers of This Study Positive by Primers C1 Age of Pigs (Week Old) Sampling Date Sampling Site (Farm) GenBank Acc. No. Porcine respiratory coronavirus Oral fluid 1 - 8 October 2020 SZ PV988448 Oral fluid 1 - 11 October 2020 SZ PV988449 Oral fluid 1 - 8–12 November 2020 ST PX677393 Oral fluid 2 2 18–20 November 2020 ST PV988450-51 Oral fluid 4 2 10 December 2020 ST PV988445-47, PX677392 Oral fluid 1 - 8–12 July 2021 KB PV988452 Nasal swab 2 2 6 June 2022 ST PV988443-44 Porcine hemagglutinating encephalomyelitis virus Oral fluid 1 - 8–12 November 2020 ST PX677397 Oral fluid 1 - 18–20 November 2020 ST PX677398 Oral fluid 1 - 20 December 2020 ST PX677399 Oral fluid 4 1 12 May 2021 CS PV988454 Oral fluid 1 1 8–12 July 2021 KB PV988453 Nasal swab 1 - 2 June 2022 SZ PX677394 Nasal swab 2 - 2 June 2022 ZM PX677395 Nasal swab 1 - 10 June 2022 ZM PX677396 As a comparison, the swine field samples were investigated with one of the previously published pan-CoV-nested PCRs (C1 primer set), showing better results with the applied ten in vitro transcribed reference RNAs. In total, 8 of the 121 specimens represented CoV sequences with the C1 primer set that were also detected with the novel oligonucleotides ( Table 3 ; Figure 3 ). Six amplicons were amplified from PRCV, while two were amplified from PHEV genomes. Figure 3 Representation of agarose gel electrophoresis of PCR products amplified by coronavirus-specific broad-spectrum oligonucleotides published previously (panel ( A ): primer set C1, 20 μL of PCR mixture) or developed in the present study (panel ( B ): 10 μL of PCR mixture). In every comparison, the amplification protocol was set to that described for the reference primer set C1. M: DNA ladder. Weak band intensity was detected in the agarose gels for further samples tested with both PCR systems. However, due to artifacts generated by the use of degenerated primers, these were not considered CoV-positive results without the opportunity of direct sequencing of the low-concentration products (for example, T25 and T26 samples, panel A; T23 sample, panel B). The determined partial PRCV and PHEV nt and aa sequences showed slight differences, even those originating from the same farm (ST) but from pigs of variable ages or from specimens collected at different dates ( Figure 4 ). Figure 4 Unrooted neighbor-joining phylogenetic trees of partial RNA-dependent RNA polymerase nucleotide (nt) and amino acid (aa) sequences generated from the genome of porcine respiratory coronavirus (PRCV, panel ( A )—nt sequences; panel ( B )—aa sequences) and porcine hemagglutinating encephalomyelitis virus (PHEV, panel ( C )—nt sequences; panel ( D )—aa sequences) identified in swine samples in Hungary (highlighted with black circles). 4. Discussion The explosion in the number of CoVs described and their importance in human and animal health led to an increased need to survey these viruses. Metagenomics is a proper tool for sequence-independent identification and comprehensive survey of viral genome diversity, but it is not an accessible and ideal method for many laboratories due to the costs and time-consuming processing. Therefore, PCR could be a simpler and, in many cases, more specific option for broad-spectrum detection of pathogens. Of course, in each case, the tools should be chosen after considering the goal of a study and the available budget. The most common method used for the diagnosis of specific CoVs is qPCR-based amplification of S-encoding genomic fragments, while, as our research confirmed, RdRp is the optimal target for broad-spectrum PCR detection. Although most pan-CoV PCR systems are appropriate for the surveillance of mammalian viruses, few also recognize avian CoVs, such as IBV [ 27 , 28 , 29 , 30 ]. The primer sets designed here were developed to identify variable coronaviruses of birds as well, with a relatively long amplicon size. The forward primers targeted a commonly used, conserved region of the CoV RdRp [ 27 , 28 , 30 , 31 , 32 ], while most of the potential reverse priming positions represented higher sequence variability; thus, they had to be carefully selected. The Rev1 primers were designed for a position that has not yet been used in the publications we have studied. One primer for a non-nested PCR was found that matched the location of the Rev2 primers [ 30 ]. To cover most of the RdRp sequence types, we designed more than one degenerate primer into a set for a given priming position to account for the variability found in the reference sequences. The choice of nucleic acid standards for optimization and comparisons is a crucial issue. Application of DNA standards, such as PCR products, cDNA, synthesized DNA, and plasmids, could result in lower LOD values for RNA viruses [ 27 , 30 , 32 ]. In contrast to the most commonly utilized DNA templates, in vitro transcribed RNAs were produced to measure the LOD that could better represent RT-PCR of an RNA virus sequence [ 28 ]. Some studies have applied cultured CoVs and assumed the sensitivity and LOD based on TCID50, PFU, and HA titers [ 29 ]. Unfortunately, the propagation of numerous CoVs remains unresolved; thus, the number of viruses that can be tested this way is limited. Additionally, it is important to note that despite calculations involving infectious virions, PCR amplifies all target RNAs, including the non-encapsidated molecules as well. To reveal the importance of enzyme usage, we tested three different RT enzymes together with random and specific primers, in normal and touchdown PCR cycling protocols on RNA standards. There was a significant difference between the efficiency of the two-step RT enzymes. The more robust and thermostable SSIV enzyme with random hexamer priming resulted in the lowest LOD values. Furthermore, touchdown PCR cycling proved to be the most suitable for annealing of the degenerated, broad-spectrum primers. In contrast to the specific RT priming, the advantage of random hexamer usage could also be exploited for the detection of co-infections of other RNA viruses, without preparation of new RT reactions. Due to different standards and amplification conditions, the LOD values reported in publications are difficult to compare. Nevertheless, the 5–50-copy LOD and the robustness of the bands achieved in this study are promising. However, as our results showed, selecting the appropriate RT enzyme and preventing nucleic acid degradation with an RNase inhibitor greatly affect the success of virus identification. To evaluate its suitability, surveillance of CoVs was conducted using the newly established RT-PCR system on swine samples. PRCV is a variant of TGEV with a deletion in the ORF S and an alteration in the ORF3 sequence, as well as scattered with point mutations [ 5 , 33 ]. The novel oligonucleotide system could detect TGEV; thus, its ability to identify PRCV was less unexpected. Due to the similarity in the RdRp sequence, distinguishing between TGEV and PRCV is hardly possible. Furthermore, in general, recombination and deletion mutations are frequent events among porcine CoVs; thus, whole-genome sequencing should be performed to identify and characterize the viruses found. The established RT-PCR was not tested with PRCV and PHEV RNA, but the results indicate its suitability for the detection of at least four swine CoVs. In Hungary, infections with PEDV, TGEV, and PRCV have been previously revealed [ 34 , 35 , 36 , 37 , 38 ]. TGEV and PRCV have been found in cases with gross pathological lesions of weight loss and dehydration and with mild villous atrophy during histopathology [ 34 ]. PEDV was first identified in 2016 in piglets with diarrhea and vomiting, causing increased mortality at a farrow-to-finish farm [ 35 ]. Subsequently, further PEDV strains have been described, showing similarities to those from Slovenia, a neighboring country of Hungary [ 37 ]. Broad-spectrum coronavirus screening has not been performed previously in healthy animals in this country. In this study, oral fluid and nasal samples of clinically healthy swine were examined with a newly established RT-PCR system to discover CoV circulation in the herds investigated. PRCV (PRCV/TGEV) and PHEV were found in all investigated age groups, suggesting that these viruses circulate at these farms without provoking any disease. PEDV was not detected at any locations. Identification of PRCV and PHEV sequences in these types of specimens is consistent with data suggesting that these viruses primarily infect cells of the respiratory (PRCV/PHEV) or gastrointestinal tract (TGEV) [ 5 ]. While TGEV is an enteral pathogen, PRCV is particularly associated with respiratory diseases [ 5 ]. However, stool specimens were not examined in this study. PHEV is characterized as the only neurotropic CoV belonging to the Betacoronavirus genus. Following infection of the initial site, the virus disseminates to the central nervous system. PHEV infection in swine is accompanied by influenza-like symptoms, vomiting, and wasting disease, as well as encephalomyelitis [ 39 , 40 , 41 ]. These viruses can be devastating for piglets, but they are often found in subclinical infections, as in the herds of the presented survey. Owing to the use of degenerated primers in broad-spectrum PCR systems, artifacts may be amplified, along with specific PCR products that are separated during gel electrophoresis. The presented PCR system contains highly degenerated oligonucleotides, which, as a limitation, implies these consequences. Therefore, verification is recommended and also needed for specific virus identification via sequencing in cases of such systems, as was carried out. Although direct sequencing was applied, multiple templates could be amplified, requiring other tools for sequence determination, such as high-throughput amplicon sequencing, which is planned to be introduced in our forthcoming studies as well. Following RT-PCR and preliminary sequence analysis for estimation of CoVs and their host spectra, complete genome sequencing can be attempted for precise classification of the viruses identified and to reveal their sequence diversity. The novel detection system is promising, but its extensive application to field samples will reveal its true utility instead of the use of RNA templates. Although genomic sequences of some CoVs of the three genera were used as standards and could be amplified, we did not have the opportunity to test the PCR with deltacoronaviruses. However, even though a few representatives are examined, it is still unclear how effective the system is in the case of other members of a genus due to the diversity of CoVs. Primer sets require constant updating to ensure the widest possible recognition of viral sequences, which could be achieved with consideration of newly described viral sequences and additional virus strains available for testing in the future. Depending on the goal, simultaneous use of more than one RT-PCR system applying primers with distinct annealing sites could also be advantageous when dealing with highly variable pathogens. Due to the limitations encountered, the primers presented are not suitable for diagnostic purposes. However, by reducing the number of degenerated sites, following extensive optimization, these may be modified to detect a narrower spectrum of CoVs that are more closely related. Overall, the broad-spectrum RT-PCR offers the possibility of widespread screening for CoVs, obtaining data that can establish further studies. 5. Conclusions The specificity and sensitivity of PCR-based broad-spectrum CoV detection systems vary. In addition, they require continuous review and adaptation to newly described coronaviruses. In this study, a pan-CoV PCR system was established that is suitable for the identification of human and animal coronaviruses. Compared to two other systems, the new primer set performed better. The study revealed that enzyme usage highly influenced the limit of detection regarding the copy number. Detection systems developed for a certain pathogenic coronavirus are more sensitive due to their specific properties. The assay described is primarily suitable for research purposes and can contribute to the assessment of the host spectrum and diversity of coronaviruses. Supplementary Materials The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/ani16030358/s1 : File S1: The primers and coronavirus RNA-dependent RNA polymerase sequences used for primer design. Author Contributions Conceptualization, E.F.; methodology, R.V.-K., E.K., B.I., G.B., Á.B. and E.F.; validation, D.M. and E.K.; investigation, D.M., R.V.-K., E.K., H.F.K., B.I., M.D., Á.B. and E.F.; resources, T.G., G.K., G.B., Á.B., Z.Z. and E.F.; data curation, E.K.; writing—original draft preparation, D.M., E.K., B.I., G.B., Z.Z. and E.F.; writing—review and editing, E.K. and E.F.; visualization, D.M. and E.F.; supervision, E.F.; project administration, D.M., R.V.-K., B.I. and E.F.; funding acquisition, T.G., G.K., G.B. and E.F. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement The animal study protocol was approved by the Ethics Committee, Department of Food Chain Safety, Animal Health, Plant Protection and Soil Conservation, National Food Chain Safety Office (ethical permission number PE/EA/544-5/2018). Informed Consent Statement Not applicable. Data Availability Statement The authors confirm that the data supporting the findings of this study are available within the article and Supplementary Material File S1 . The partial genome sequences have been deposited in the GenBank database with accession numbers (GenBank acc. nos. PV9488443-PV9488453 and PX677392-PX677399 ). Conflicts of Interest Renáta Varga-Kugler and Ádám Bálint are employees of Ceva-Phylaxia Ltd. and Vetcontrol Ltd., respectively. However, their work was carried out independently of the referred companies, before they began their employment, in co-operation with the HUN-REN Veterinary Medical Research Institute, Budapest, Hungary. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Funding Statement This work was supported by the National Research, Development, and Innovation Office, grant numbers FK154149 and FK137778. Further support was provided by the National Research, Development, and Innovation Office, project name National Laboratory for Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health, and Food Chain Safety, grant number RRF-2.3.1-21-2022-00001. Project no. 2024-2.1.1-EKÖP-2024-00018 has been implemented with support provided by the Ministry of Culture and Innovation of Hungary from the National Research, Development, and Innovation Fund, financed under the 2024-2.1.1-EKÖP funding scheme. Footnotes Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. References 1. Fehér E., Kemenesi G., Görföl T., Wazzani Y., Bodó K., Lanszki J., Máté D., Kaszab E., Domán M., Zádori Z., et al. Occurrence of Recombinant Canine Coronavirus, Picodicistrovirus, and Circovirus in Red Foxes (Vulpes vulpes) Implies Frequent Virus Transmission Events Among Carnivores. Transbound. Emerg. Dis. 2025;2025:6681119. doi: 10.1155/tbed/6681119. 2. Islam A., Ferdous J., Islam S., Sayeed M.A., Dutta Choudhury S., Saha O., Hassan M.M., Shirin T. Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife. Viruses. 2021;13:1908. doi: 10.3390/v13101908. 3. Milich K.M., Morse S.S. The reverse zoonotic potential of SARS-CoV-2. Heliyon. 2024;10:e33040. doi: 10.1016/j.heliyon.2024.e33040. 4. Ruiz-Aravena M., McKee C., Gamble A., Lunn T., Morris A., Snedden C.E., Yinda C.K., Port J.R., Buchholz D.W., Yeo Y.Y., et al. Ecology, evolution and spillover of coronaviruses from bats. Nat. Rev. Microbiol. 2022;20:299–314. doi: 10.1038/s41579-022-00691-3. 5. Thakor J.C., Dinesh M., Manikandan R., Bindu S., Sahoo M., Sahoo D., Dhawan M., Pandey M.K., Tiwari R., Emran T.B., et al. Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns. Vet. Q. 2022;42:125–147. doi: 10.1080/01652176.2022.2079756. 6. Wells H.L., Bonavita C.M., Navarrete-Macias I., Vilchez B., Rasmussen A.L., Anthony S.J. The coronavirus recombination pathway. Cell Host Microb. 2023;31:874–889. doi: 10.1016/j.chom.2023.05.003. 7. Ye Z.W., Yuan S., Yuen K.S., Fung S.Y., Chan C.P., Jin D.Y. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 2020;16:1686–1697. doi: 10.7150/ijbs.45472. 8. International Committee on Taxonomy of Viruses: ICTV. [(accessed on 30 August 2025)]. Available online: https://ictv.global/taxonomy . 9. Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92:418–423. doi: 10.1002/jmv.25681. Erratum in J. Med. Virol.

2020, 92, 2249. https://doi.org/10.1002/jmv.26234. 10. Tang G., Liu Z., Chen D. Human coronaviruses: Origin, host and receptor. J. Clin. Virol. 2022;155:105246. doi: 10.1016/j.jcv.2022.105246. 11. Chu D.K., Poon L.L., Gomaa M.M., Shehata M.M., Perera R.A., Abu Zeid D., El Rifay A.S., Siu L.Y., Guan Y., Webby R.J., et al. MERS coronaviruses in dromedary camels. Egypt. Emerg. Infect. Dis. 2014;20:1049–1053. doi: 10.3201/eid2006.140299. 12. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. doi: 10.1016/S0140-6736(03)13077-2. 13. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721. 14. Balka G., Bálint Á., Cságola A., Farsang A., Kiss I., Zádori Z. The biology of coronaviruses, with special regards to SARS-CoV-2-and COVID-19. Magy. Allatorvosok Lapja. 2020;142:259–277. (In Hungarian) 15. Balka G., Bálint Á., Cságola A., Farsang A., Jerzsele Á., Kiss I., Zádori Z. Vaccine developments and pharmacological treatment options against SARS-CoV-2 infection and the control of coronaviruses in domestic animals Literature review. Magy. Allatorvosok Lapja. 2020;142:323–348. (In Hungarian) 16. Buonavoglia A., Pellegrini F., Decaro N., Galgano M., Pratelli A. A One Health Perspective on Canine Coronavirus: A Wolf in Sheep’s Clothing? Microorganisms. 2023;11:921. doi: 10.3390/microorganisms11040921. 17. Liu Q., Wang H.Y. Porcine enteric coronaviruses: An updated overview of the pathogenesis, prevalence, and diagnosis. Vet. Res. Commun. 2021;45:75–86. doi: 10.1007/s11259-021-09808-0. 18. Perfilyeva Y.V., Zhigailov A.V., Malysheva A.A., Cherusheva A.S., Ivanova K.R., Berdygulova Z.A., Bissenbay A.O., Kuatbekova S.A., Dosmagambet Z.M., Lushova A.V., et al. Occurrence and epidemiology of bovine coronavirus in cattle in Kazakhstan. Vet. J. 2025;24:106371. doi: 10.1016/j.tvjl.2025.106371. 19. Pusterla N., Vin R., Leutenegger C.M., Mittel L.D., Divers T.J. Enteric coronavirus infection in adult horses. Vet. J. 2018;231:13–18. doi: 10.1016/j.tvjl.2017.11.004. 20. Wang Q., Vlasova A.N., Kenney S.P., Saif L.J. Emerging and re-emerging coronaviruses in pigs. Curr. Opin. Virol. 2019;34:39–49. doi: 10.1016/j.coviro.2018.12.001. 21. Zhang L., Liu J.B., Liu H.Z., Lian Y.X., Huang Y.W., Cong F. The Emergence of Novel Variants of the Porcine Epidemic Diarrhea Virus Spike Gene from 2011 to 2023. Transbound. Emerg. Dis. 2024;2024:2876278. doi: 10.1155/2024/2876278. 22. Kemenesi G., Dallos B., Görföl T., Boldogh S., Estók P., Kurucz K., Kutas A., Földes F., Oldal M., Németh V., et al. Molecular survey of RNA viruses in Hungarian bats: Discovering novel astroviruses, coronaviruses, and caliciviruses. Vector Borne Zoonotic Dis. 2014;14:846–855. doi: 10.1089/vbz.2014.1637. 23. Igriczi B., Dénes L., Czétényi A., Révész T., Somogyi Z., Balka G. Prevalence Estimation and Genetic Characterization of Porcine Parainfluenza Virus 1 (PPIV-1) in Hungary and the First Report of the Virus in Slovakia. Transbound. Emerg. Dis. 2024;2024:5534854. doi: 10.1155/2024/5534854. 24. Igriczi B., Dénes L., Schönhardt K., Woźniak A., Stadejek T., Balka G. Comparative Prevalence Estimation and Phylogenetic Analysis of Novel Porcine Parvoviruses (PPV2-7) in Hungarian Pig Herds. Transbound. Emerg. Dis. 2024;2024:5117884. doi: 10.1155/2024/5117884. 25. Basic Local Alignment Search Tool: BLAST. [(accessed on 12 December 2025)]; Available online: https://blast.ncbi.nlm.nih.gov/Blast.cgi . 26. Kumar S., Stecher G., Li M., Knyaz C., Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across computing platforms. Mol. Biol. Evol. 2018;35:1547–1549. doi: 10.1093/molbev/msy096. 27. Holbrook M.G., Anthony S.J., Navarrete-Macias I., Bestebroer T., Munster V.J., van Doremalen N. Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera. Viruses. 2021;13:599. doi: 10.3390/v13040599. 28. de Souza Luna L.K., Heiser V., Regamey N., Panning M., Drexler J.F., Mulangu S., Poon L., Baumgarte S., Haijema B.J., Kaiser L., et al. Generic Detection of Coronaviruses and Differentiation at the Prototype Strain Level by Reverse Transcription-PCR and Nonfluorescent Low-Density Microarray. J. Clin. Microbiol. 2007;45:1049–1052. doi: 10.1128/JCM.02426-06. 29. Drzewnioková P., Festa F., Panzarin V., Lelli D., Moreno A., Zecchin B., De Benedictis P., Leopardi S. Best Molecular Tools to Investigate Coronavirus Diversity in Mammals: A Comparison. Viruses. 2021;13:1975. doi: 10.3390/v13101975. 30. Hu H., Jung K., Wang Q., Saif L.J., Vlasova A.N. Development of a one-step RT-PCR assay for detection of pancoronaviruses (α-, β-, γ-, and δ-coronaviruses) using newly designed degenerate primers for porcine and avian fecal samples. J. Virol. Methods. 2018;256:116–122. doi: 10.1016/j.jviromet.2018.02.021. 31. Chu D.K., Leung C.Y., Gilbert M., Joyner P.H., Ng E.M., Tse T.M., Guan Y., Peiris J.S., Poon L.L. Avian coronavirus in wild aquatic birds. J. Virol. 2011;85:12815–12820. doi: 10.1128/JVI.05838-11. 32. Xiu L., Binder R.A., Alarja N.A., Kochek K., Coleman K.K., Than S.T., Bailey E.S., Bui V.N., Toh T.H., Erdman D.D., et al. A RT-PCR assay for the detection of coronaviruses from four genera. J. Clin. Virol. 2020;128:104391. doi: 10.1016/j.jcv.2020.104391. 33. Olech M., Antas M. Transmissible Gastroenteritis Virus (TGEV) and Porcine Respiratory Coronavirus (PRCV): Epidemiology and Molecular Characteristics-An Updated Overview. Viruses. 2025;17:493. doi: 10.3390/v17040493. 34. Lőrincz M., Biksi I., Andersson S., Cságola A., Tuboly T. Sporadic re-emergence of enzootic porcine transmissible gastroenteritis in Hungary. Acta Vet. Hung. 2014;62:125–133. doi: 10.1556/avet.2013.043. 35. Valkó A., Biksi I., Cságola A., Tuboly T., Kiss K., Ursu K., Dán Á. Porcine epidemic diarrhoea virus with a recombinant S gene detected in Hungary, 2016. Acta Vet. Hung. 2017;65:253–261. doi: 10.1556/004.2017.025. 36. Valkó A., Tuboly T., Cságola A. Enteral coronaviruses of swine. Magy. Allatorvosok Lapja. 2018;140:207–216. (In Hungarian) 37. Valkó A., Albert E., Cságola A., Varga T., Kiss K., Farkas R., Rónai Z., Biksi I., Dán Á. Isolation and characterisation of porcine epidemic diarrhoea virus in Hungary. Acta Vet. Hung. 2019;67:307–313. doi: 10.1556/004.2019.031. 38. Valkó A., Bálint Á., Bozsa Á., Cságola A. Prevalence of antibodies against transmissible gastroenteritis virus (TGEV) in Hungary. Vet. Anim. Sci. 2019;7:100042. doi: 10.1016/j.vas.2018.11.003. 39. Li Z., He W., Lan Y., Zhao K., Lv X., Lu H., Ding N., Zhang J., Shi J., Shan C., et al. The evidence of porcine hemagglutinating encephalomyelitis virus induced nonsuppurative encephalitis as the cause of death in piglets. PeerJ. 2016;15:2443. doi: 10.7717/peerj.2443. 40. Lorbach J.N., Wang L., Nolting J.M., Benjamin M.G., Killian M.L., Zhang Y., Bowman A.S. Porcine Hemagglutinating Encephalomyelitis Virus and Respiratory Disease in Exhibition Swine, Michigan, USA, 2015. Emerg. Infect. Dis. 2017;23:1168–1171. doi: 10.3201/eid2307.170019. 41. Roe C.K., Alexander T.J. A Disease of nursing pigs previously unreported in Ontario. Can. J. Comp. Med. Vet. Sci. 1958;22:305–307. Associated Data Supplementary Materials Data Availability Statement The authors confirm that the data supporting the findings of this study are available within the article and Supplementary Material File S1 . The partial genome sequences have been deposited in the GenBank database with accession numbers (GenBank acc. nos. PV9488443-PV9488453 and PX677392-PX677399 ).

📖 中文全文 Chinese Full Text

中文

2763 动物 Animals:MDPI 开放获取期刊 Animals (Basel) 多学科数字出版研究所 (MDPI) PMC12896397 12896397 12896397 41681341 10.3390/ani16030358 利用新建立的泛冠状病毒RT-PCR系统对匈牙利猪群进行冠状病毒监测 Máté Dóra 验证、调查、撰写初稿、可视化、项目管理 1 Varga-Kugler Renáta 方法学、调查、项目管理 2 Kaszab Eszter 方法学、验证、调查、数据管理、撰写初稿、撰写审阅与编辑 1 3 4 * Károlyi Henrik Fülöp 调查 5 Görföl Tamás 资源、经费获取 5 Kemenesi Gábor 资源、经费获取 5 6 Igriczi Barbara 方法学、调查、撰写初稿、项目管理 3 7 Balka Gyula 方法学、资源、撰写初稿、经费获取 3 7 Domán Marianna 调查 8 Bálint Ádám 方法学、调查、资源 9 Zádori Zoltán 资源、撰写初稿 8 Fehér Enikő 概念化、方法学、调查、资源、撰写初稿、撰写审阅与编辑、可视化、监督、项目管理、经费获取 1 3 5 Marsilio Fulvio 学术编辑 1 布达佩斯兽医大学微生物学与传染病学系,匈牙利布达佩斯,Hungária krt. 23-25, H-1143 2 Ceva-Phylaxia 有限公司,匈牙利布达佩斯,Szállás utca 5, H-1107 3 国家感染性动物疾病、抗菌素耐药性、兽医公共卫生与食品安全实验室,匈牙利布达佩斯,István utca 2, H-1078 4 德布勒森大学健康科学学院生物信息学系,匈牙利德布勒森,Nagyerdei krt. 98, H-4032 5 佩奇大学圣捷尔吉研究中心国家病毒学实验室,匈牙利佩奇,Ifjúság útja 20, H-7624 6 佩奇大学理学院生物学系,匈牙利佩奇,Ifjúság útja 6, H-7624 7 布达佩斯兽医大学病理学系,匈牙利布达佩斯,István utca 2, H-1078 8 HUN-REN 兽医医学研究所,匈牙利布达佩斯,Hungária krt. 21, H-1143 9 Vetcontrol 有限公司,匈牙利布达佩斯,Déli-Bekötő út 8, H-1211 * 通信作者:kaszab.eszter@univet.hu 2026年1月23日 16 3 358 358 2026年2月13日 © 2026 作者所有。许可方:MDPI,瑞士巴塞尔。本文为根据 Creative Commons Attribution (CC BY) 许可条款和条件分发的开放获取文章。

**简单摘要** 由于 SARS-CoV-2 大流行,我们对冠状病毒已有所了解。这些病毒具有高度多样性且快速变化的基因组,有助于其广泛分布并传播给新的宿主。尽管已有多种简便的病毒特异性检测方法可用于检测最重要的致病性冠状病毒,但识别新病毒和变异株需要不同的方法。在本研究中,我们开发了一种冠状病毒广谱检测系统。使用十种感染人类和动物的冠状病毒测定了该检测方法的灵敏度,并与其他系统进行了比较。新方法的应用证明了冠状病毒在猪群中的循环,以及所建立工具对其检测的适用性。本文所述检测方法主要用于研究目的,可显著增进我们对冠状病毒多样性和宿主谱的了解,并有助于我们应对新病原体的出现。

**关键词:** 泛冠状病毒,PCR,哺乳动物,禽类,人类,猪

**摘要** 冠状病毒(CoVs)的快速演化要求研究人员开发特异性高且广谱的检测方法,以监测其持续的基因组变化。本研究旨在建立一套当前的泛冠状病毒RT-PCR系统,能够检测多种CoV,并适用于病毒多样性和宿主谱的研究。为优化反应体系,我们检测了一步法和两步法嵌套RT-PCR,使用三种不同的RT酶,扩增RNA依赖性RNA聚合酶(RdRp)约600 bp的产物。作为模板,使用了十种致病性CoV的体外转录RNA(SARS-CoV、SARS-CoV-2、NL-63、OC43、猫冠状病毒、猪流行性腹泻病毒(PEDV)、猪传染性胃肠炎病毒(TGEV)、犬冠状病毒、蝙蝠冠状病毒和传染性支气管炎病毒),而非常用的DNA标准品。采用随机六聚体引物引发的两步RT-PCR结合降落循环程序,实现了5–50拷贝/反应的检出限,与先前发表的引物组相比,具有更低的检出限和更高的特异性。使用新建的RT-PCR系统对采集自匈牙利临床健康猪群的混合样本(n = 121)进行了检测。在24份口腔液和鼻腔拭子混合样本中鉴定出猪呼吸道冠状病毒(PRCV)/TGEV和猪血凝性脑脊髓炎病毒(PHEV)序列,证明了这些病毒在该国猪群中的循环,以及新建PCR方法对其检测的适用性。结果强调了选择合适的RT酶以及在样本制备和保存中使用RNase抑制剂的重要性。

**状态** 已发布 **显示PDF** 是 **是否为OLF** 否 **是否为手稿** 否 **是否为预印本** 否 **是否为期刊内容** 否 **是否为扫描件** 否 **是否为撤稿** 否 收稿日期:2025年12月18日;修回日期:2026年1月16日;接受日期:2026年1月20日;数据收录日期:2026年2月。

**1. 引言** 大多数人将冠状病毒(CoV)一词与疾病名称COVID-19及其病原体——严重急性呼吸综合征冠状病毒2(SARS-CoV-2)联系起来。然而,具有重要兽医意义的冠状病毒同样广泛存在。基因组和系统发育分析揭示了冠状病毒复杂而隐蔽的进化过程。一个众所周知的现象是,在多种冠状病毒共同感染的情况下容易发生重组。重组以及由RNA依赖性RNA聚合酶(RdRp)驱动的核苷酸不精确掺入所导致的突变积累,赋予了冠状病毒高度的适应性,从而促使新病毒的出现和传播,以及跨物种传播。溢出事件可能导致人畜共患病,并暗示人类与哺乳动物之间存在反向人畜共患感染的可能性[1–7]。

冠状病毒(冠状病毒科,网巢病毒目)分为α、β、γ和δ冠状病毒属[8]。α和β冠状病毒属包括哺乳动物和人类相关病毒,而γ和δ冠状病毒属则包含感染哺乳动物和鸟类的病毒[8]。病毒粒子具有包膜,基因组为长约25–31 kb的正链单股RNA。其基因组结构高度多样;非结构蛋白的开放阅读框(ORF)1a和1b,以及核衣壳(N)、刺突(S)、膜(M)和包膜(E)蛋白的ORF均按此顺序排列,而编码辅助蛋白的基因数量和功能即使在毒株间也存在差异[9]。作为研究广泛且常见的诊断靶标,S蛋白在种间表现出高度变异性。它介导受体结合、病毒进入细胞以及免疫系统的激活[9]。

冠状病毒可引起各种类型和严重程度的疾病。人类常遇到由HCoV-229E、HCoV-NL63、HCoV-OC43或HCoV-HKU1引起的类似普通感冒的症状[10]。最臭名昭著的、与人类相关的人畜共患冠状病毒(SARS-CoV、SARS-CoV-2和中东呼吸综合征冠状病毒)可导致全身性甚至致命的症候群[10–13]。在冠状病毒感染的兽医方面,可识别出几种具有重要经济意义的冠状病毒,包括传染性支气管炎病毒(IBV)、牛冠状病毒、猫冠状病毒(FCoV)、犬冠状病毒(CCoV)和猪冠状病毒(猪流行性腹泻病毒(PEDV);猪传染性胃肠炎病毒(TGEV);猪呼吸道冠状病毒(PRCV,TGEV的缺失变异株);猪血凝性脑脊髓炎病毒(PHEV);猪急性腹泻综合征冠状病毒;猪δ冠状病毒)[1,4,5,14–21]。由于蝙蝠冠状病毒在冠状病毒进化中的重要作用,对其进行监测无疑非常重要[4,22]。

早期识别冠状病毒感染及其新出现的变异株对人类和动物医疗保健具有重要意义。然而,由于其基因组多样性,总体检测具有挑战性。本研究旨在开发一种具有最广泛特异性的通用泛冠状病毒检测系统,主要用于研究人员揭示冠状病毒的多样性和基因组变化。该方法已使用三种不同的RT酶成功应用于人类和动物冠状病毒分离株及样本。对猪的实地样本进行了调查,除PRCV/TGEV外,还鉴定出了PHEV序列。根据对照和实地样本的收集,与先前发表的寡核苷酸相比,本文所述引物具有更高的特异性。

**2. 材料与方法**

**2.1. 样本** 动物来源的临床样本(蝙蝠、猪、犬、家禽)和冠状病毒分离株(FCoV、NL-63、OC43)由匈牙利布达佩斯兽医大学病理学系、匈牙利布达佩斯HUN-REN兽医医学研究所以及匈牙利佩奇大学圣捷尔吉研究中心国家病毒学实验室提供。按照制造商说明书,使用NucleoSpin RNA Virus试剂盒(Macherey-Nagel,德国杜伦)提取核酸。SARS-CoV和SARS-CoV-2变异株“alpha”、“delta”和“omicron”的RNA由匈牙利佩奇大学圣捷尔吉研究中心国家病毒学实验室在符合相应生物安全要求的情况下提取并提供。

总共对121份临床健康猪的混合口腔液(n = 84,每栏一根采样绳)、鼻腔拭子(n = 34,每份样本混合4–5头猪的样本,共162头动物)和断尾液(n = 3,在阉割过程中获取)样本进行了CoV检测。这些样本于2020年至2022年间从匈牙利养猪场采集,来自3–7日龄仔猪(断尾液)、2–10周龄(鼻腔拭子)和8–12周龄(口腔液)的猪,以及17–30周龄的育肥猪(口腔液),这些猪在采样期间均未表现出临床疾病症状[23,24]。就类型而言,这些是工业化生产的自繁自养场,遗传背景和母猪群规模(520–2200头母猪)存在差异[23,24]。在数据可用的猪群中未接种冠状病毒疫苗。使用QIAmp cador Pathogen Mini Kit(QIAGEN,德国希尔德恩)在QIAcube仪器上按照说明书提取核酸。

**2.2. RT与PCR** 为初步测试寡核苷酸,使用SuperScript IV逆转录酶(SSIV,Thermo Scientific,美国马萨诸塞州沃尔瑟姆)进行RT步骤。第一步,将以下组分混合并在65°C孵育5分钟,然后置于冰上:7.5 µL无核酸酶水、1 µL 50 µM随机六聚体引物混合物、1 µL 10 mM dNTP混合物和5 µL RNA模板。第二步,加入4 µL 5× SSIV缓冲液、0.5 µL RiboLock RNase抑制剂(Thermo Scientific,美国马萨诸塞州沃尔瑟姆)和1 µL SSIV酶,使终体积达到20 µL,混合物在23°C孵育10分钟、55°C孵育10分钟、80°C孵育10分钟。SSIV也用于带有可变CoV特异性反向引物组的RT,使用1 µL 10 µM引物混合物(表1),孵育程序为55°C 10分钟和80°C 10分钟。

**表1 本研究中描述的寡核苷酸序列。**

| 引物组 | 引物序列 5′–3′ | | :--- | :--- | | **半嵌套PCR** | | | Fw-mix | GGNTGGGAYTAYCCNAAATGTGA
GGNTGGGAYTAYCCNAAGTGCGA
GGNTGGGAYTAYCCNAAGTGTGA | | Rev-mix1 | ARNGGRTANGCRTCWATTGC
ARNGGRTANGCRTCWATGGC
ARNGGRTANGCRTCWATAGC | | Rev-mix2 | TGYTGNGARCARAAYTCRTGNGGTCC
TGYTGNGARCARAAYTCRTGNGGACC
TGYTGNGARCARAAYTCRTGNGGGCC
TGYTGNGARCARAAYTCRTGNGGCCC | | **体外转录** | | | Fw-T7-mix | TAATACGACTCACTATAGGGGGNTGGGAYTAYCCNAAATGTGA
TAATACGACTCACTATAGGGGGNTGGGAYTAYCCNAAGTGCGA
TAATACGACTCACTATAGGGGGNTGGGAYTAYCCNAAGTGTGA | | Rev-T7-mix | TCCTCCTCCTCCARNGGRTANGCRTCWATTGC
TCCTCCTCCTCCARNGGRTANGCRTCWATGGC
TCCTCCTCCTCCARNGGRTANGCRTCWATAGC |

RevertAid逆转录酶(Thermo Scientific,美国马萨诸塞州沃尔瑟姆)按照与SSIV描述相同的程序进行测试。混合物在25°C孵育10分钟、50°C孵育60分钟、70°C孵育10分钟。

从GenBank获取冠状病毒序列并进行比对以设计PCR引物(文件S1)。冠状病毒特异性嵌套PCR在25 μL体积中进行,包含1× DreamTaq Green缓冲液、200 μM dNTP混合物、400 nM Fw-mix1引物、400 nM Rev-mix1/Rev-mix2引物(分别用于嵌套方案的第一轮和第二轮PCR,表1)、0.75 U DreamTaq DNA聚合酶(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆)和2 μL RT反应混合物。标准循环程序包括95°C初始变性5分钟;35/40个循环(分别用于嵌套方案的第一轮和第二轮PCR),步骤为95°C变性30秒、53°C引物退火30秒、72°C延伸1分钟;以及72°C最终延伸10分钟。嵌套PCR第一轮的降落循环程序如下:95°C初始变性3分钟;10个循环:95°C变性30秒、62–53°C引物退火30秒(每循环降低1°C)、72°C延伸1分钟;30个循环:95°C变性30秒、53°C引物退火30秒、72°C延伸1分钟;72°C最终延伸5分钟。降落循环后,嵌套方案的第二轮PCR与上述嵌套PCR描述相同。

一步法RT-PCR使用QIAGEN OneStep RT-PCR试剂盒(QIAGEN,德国希尔德恩)在25 μL体积中进行,包含1× QIAGEN One-Step RT-PCR缓冲液、400 nM Fw-mix引物、600 nM Rev-mix1引物(表1)、400 μM dNTP混合物、0.6 μL RiboLock RNase抑制剂、1 μL OneStep酶混合物和5 μL纯化核酸。循环程序如下:RT步骤50°C 30分钟和95°C 15分钟;10个循环:94°C变性20秒、62–53°C引物退火30秒(每循环降低1°C)、72°C延伸1分钟;30个循环:95°C变性30秒、53°C引物退火30秒、72°C延伸1分钟;72°C最终延伸10分钟。一步法RT-PCR后,嵌套方案的第二轮PCR与使用DreamTaq DNA聚合酶(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆)的其他PCR描述相同。

将约600 bp的PCR产物从琼脂糖凝胶中使用NucleoSpin Gel和PCR纯化试剂盒(Macherey-Nagel,德国杜伦)纯化,并由服务公司进行Sanger测序以确认序列。使用嵌套PCR扩增将新寡核苷酸与先前发表的引物进行比较,设置参照方案中描述的条件,结合使用SSIV逆转录酶(Thermo Scientific,美国马萨诸塞州沃尔瑟姆)和DreamTaq DNA聚合酶(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆),或QIAGEN OneStep RT-PCR试剂盒(QIAGEN,德国希尔德恩)和DreamTaq DNA聚合酶(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆)。泛-CoV PCR是在使用SSIV(Thermo Scientific,美国马萨诸塞州沃尔瑟姆)进行RT步骤后,对120份猪混合样本进行的,如上文所述。本研究开发的嵌套PCR引物按照降落循环方案应用,详见第2.3节。

**2.3. 体外转录** 使用TranscriptAid T7高产量转录试剂盒(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆)按照制造商说明书通过体外转录生成RNA标准品。T7启动子序列通过正向寡核苷酸Fw-T7-mix掺入线性DNA模板中,而Rev-T7-mix的反向引物在5'端含有延伸序列(表1)。转录后,使用NucleoSpin RNA Virus试剂盒(Macherey-Nagel,德国杜伦)纯化约793 bp的RNA标准品,并在补充有RiboLock RNase抑制剂(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆)的无核酸酶水中于–70°C保存。使用NanoDrop分光光度计(Thermo Fisher Scientific,美国马萨诸塞州沃尔瑟姆)测量RNA标准品的浓度,并在含有RNase抑制剂的无核酸酶水中制备RNA的十倍系列稀释液。拷贝数设置为每PCR反应5 × 10⁴ – 5 × 10⁰个RNA拷贝。

**2.4. 软件** 根据文献选择冠状病毒参考序列并从GenBank获取以设计引物。使用Geneious Prime v.2024.0.3(Biomatters,新西兰奥克兰)的MAFFT算法生成RdRp序列的核苷酸比对。使用基本局部比对搜索工具(BLAST,在线平台)检查生成的序列[25]。使用MEGA X软件、邻接法和p-distance模型进行系统发育分析,使用1000个自举重复[26]。

**3. 结果** 正如根据序列比对所预期的,RdRp基因被证明是广谱PCR扩增最合适的靶标。使用临床样本和CoV分离株进行初步寡核苷酸测试和体外转录,样本来源包括人类(α-CoV:NL-63;β-CoV:SARS-CoV、SARS-CoV-2变异株“alpha”、“delta”和“omicron”以及OC43分离株)和动物(α-CoV:从患有猫传染性腹膜炎的猫中分离的FCoV、CCoV、PEDV、TGEV和蝙蝠冠状病毒;γ-CoV:IBV)。遗憾的是,无法获得含有δ-CoV的标本。在可用的情况下,使用一种以上相应冠状病毒的标本测试了寡核苷酸(蝙蝠冠状病毒、CCoV、PEDV、TGEV、IBV和SARS-CoV-2变异株)。使用涉及SSIV逆转录酶和DreamTaq DNA聚合酶的基本方案检测了大量简并寡核苷酸。使用最合适的正向和反向引物混合物进行了进一步优化。使用随机六聚体和CoV特异性反向引物组进行RT。在矩阵中研究了退火温度,寡核苷酸可耐受宽范围的温度。选择53°C作为后续实验的退火温度。最终,在随机六聚体RT引发后,适用于半嵌套PCR的引物组合产生了最稳健的结果,包含一个正向和两个反向引物组(Fw-mix、Rev-mix1和Rev-mix2,表1)。第一轮PCR扩增了约760 bp的冠状病毒RdRp片段,而第二轮嵌套PCR产物约600 bp长。尽管第一轮PCR的扩增子可在琼脂糖凝胶上显现,但其条带强度低于第二轮嵌套PCR。在使用所选引物组优化泛-CoV半嵌套PCR的过程中,持续评估了先前定义的因素(如引物浓度、退火温度或扩增循环数)的适用性。第一轮PCR使用30–45个循环、嵌套PCR使用35–45个循环时扩增效率良好。虽然两种方法都有效,但随机六聚体比Rev-mix1更适合RT引发。

为确定RT-PCR的检出限(LOD),通过体外转录生成RNA标准品。测量质量和数量后,从RNA制备十倍系列稀释液,每反应5 × 10⁴ – 5 × 10⁰个RNA拷贝。对RNA系列进行三次检测,实验至少重复三次。体外转录RNA的稀释液分别在含和不含RNase抑制剂的情况下制备。当使用抑制酶时,LOD值要好得多(一到两个数量级),尽管RNA总是用无核酸酶水和塑料实验器具新鲜稀释。使用两种RT酶(SSIV和RevertAid逆转录酶)和随机六聚体进行RT,以及使用一步法RT-PCR(QIAGEN OneStep RT-PCR试剂盒)和Rev-mix1寡核苷酸组进行RT。RT步骤后进行半嵌套PCR,而一步法RT-PCR后进行单轮嵌套PCR。除了在53°C退火的标准化循环程序外,还评估了降落循环。在大多数情况下,使用SSIV RT酶和随机六聚体结合新引物组和第一轮PCR中的降落循环程序获得了最低的LOD值,略低于一步法RT-PCR方案的LOD值(图1,表2)。使用RevertAid RT酶获得的LOD值比其他两种RT酶(SSIV和OneStep RT-PCR酶)高几个数量级(表2)。

**图1** 通过新建立的冠状病毒特异性广谱半嵌套RT-PCR从体外转录的猫冠状病毒RNA依赖性RNA聚合酶片段扩增产物的琼脂糖凝胶电泳图(来自两个RNA稀释系列的六次重复)。使用随机六聚体引发进行逆转录。半嵌套扩增反应的第一轮PCR采用降落循环程序进行。数值表示以拷贝/反应表示的检出限。M:DNA分子量标准。

**表2 使用可变逆转录酶和降落PCR程序测定的新冠状病毒特异性引物的检出限值(拷贝/反应)。**

| 病毒 | SuperScript IV RT | QIAGEN One-Step RT-PCR | RevertAid RT | | :--- | :--- | :--- | :--- | | SARS-CoV | 5 × 10¹ | 5 × 10² | 5 × 10² | | SARS-CoV-2 | 5 × 10¹ | 5 × 10² | 5 × 10² | | OC43 | 5 × 10⁰ | 5 × 10¹ | 5 × 10³ | | NL-63 | 5 × 10¹ | 5 × 10² | 5 × 10² | | PEDV | 5 × 10⁰ | 5 × 10¹ | 5 × 10² | | TGEV | 5 × 10¹ | 5 × 10² | 5 × 10¹ | | CCoV | 5 × 10⁰ | 5 × 10¹ | 5 × 10² | | FCoV | 5 × 10¹ | 5 × 10¹ | 5 × 10¹ | | Bat | 5 × 10¹ | 5 × 10² | 5 × 10¹ | | IBV | 5 × 10⁰ | 5 × 10² | 5 × 10³ |

将新寡核苷酸与先前发表的相关文献中描述的另外两组广谱CoV特异性引物组(C1和C2)进行比较,对引物Fw-mix、Rev-mix1和Rev-mix2应用参照的RT酶和循环程序。总体而言,新设计的引物产生了更低的LOD值和更高的特异性(先前发表的引物未对所有RNA标准品呈现阳性),并在琼脂糖凝胶中产生了比其他两组引物更强的条带(图2)。

**图2** 通过先前发表(面板A:引物组C1;面板B:引物组C2)或本研究开发的冠状病毒特异性广谱寡核苷酸扩增产物的琼脂糖凝胶电泳图。在每次比较中,扩增程序设置为针对参考引物C1和C2描述的程序,并将其应用于新引物组。数值表示以拷贝/反应表示的检出限,针对体外转录的蝙蝠和猫冠状病毒(面板A)以及SARS-CoV-2(面板B)RNA依赖性RNA聚合酶片段获得。M:DNA分子量标准。

为评估其有效性,将此处开发的PCR系统用于检测121份猪混合样本,并在24份(19.8%)中鉴定出CoV序列(表3)。尽管可在同一反应中扩增多种冠状病毒的RdRp片段,但Sanger测序在每个样本中仅鉴定出一种病毒(GenBank登录号PV9488443-PV9488453和PX677392-PX677399)。其中12个序列与GenBank中保存的PRCV序列(99.64%核苷酸一致性)和PHEV序列(99.10%核苷酸一致性)具有最高一致性。两份鼻腔拭子样本PRCV检测呈阳性,四份PHEV检测呈阳性,而其他18份为口腔液标本,其中10份为PRCV,8份为PHEV序列。在匈牙利五个不同的定居点/农场发现了鉴定的冠状病毒,其中两个同时存在PRCV和PHEV(用字母ST和KB标记)(表3)。

**表3 使用新寡核苷酸和方案(本研究)以及先前发表的(C1)泛冠状病毒嵌套PCR对猪样本进行冠状病毒监测的结果,仅显示检测呈阳性的样本。**

| 样本类型 | 本研究引物阳性 | C1引物阳性 | 猪周龄 | 采样日期 | 采样地点(农场) | GenBank登录号 | | :--- | :---: | :---: | :--- | :--- | :--- | :--- | | **猪呼吸道冠状病毒** | | | | | | | | 口腔液 | 1 | - | 8 | 2020年10月 | SZ | PV988448 | | 口腔液 | 1 | - | 11 | 2020年10月 | SZ | PV988449 | | 口腔液 | 1 | - | 8–12 | 2020年11月 | ST | PX677393 | | 口腔液 | 2 | 2 | 18–20 | 2020年11月 | ST | PV988450-51 | | 口腔液 | 4 | 2 | 10 | 2020年12月 | ST | PV988445-47, PX677392 | | 口腔液 | 1 | - | 8–12 | 2021年7月 | KB | PV988452 | | 鼻腔拭子 | 2 | 2 | 6 | 2022年6月 | ST | PV988443-44 | | **猪血凝性脑脊髓炎病毒** | | | | | | | | 口腔液 | 1 | - | 8–12 | 2020年11月 | ST | PX677397 | | 口腔液 | 1 | - | 18–20 | 2020年11月 | ST | PX677398 | | 口腔液 | 1 | - | 20 | 2020年12月 | ST | PX677399 | | 口腔液 | 4 | 1 | 12 | 2021年5月 | CS | PV988454 | | 口腔液 | 1 | 1 | 8–12 | 2021年7月 | KB | PV988453 | | 鼻腔拭子 | 1 | - | 2 | 2022年6月 | SZ | PX677394 | | 鼻腔拭子 | 2 | - | 2 | 2022年6月 | ZM | PX677395 | | 鼻腔拭子 | 1 | - | 10 | 2022年6月 | ZM | PX677396 |

作为比较,使用先前发表的泛-CoV嵌套PCR(C1引物组)对猪实地样本进行了调查,该引物组在使用十种体外转录的参考RNA时表现出更好的结果。总共有8份样本通过C1引物组呈现了CoV序列,这些序列也通过新寡核苷酸检测到(表3;图3)。其中6个扩增子来自PRCV,2个来自PHEV基因组。

**图3** 通过先前发表(面板A:引物组C1,20 μL PCR混合物)或本研究开发(面板B:10 μL PCR混合物)的冠状病毒特异性广谱寡核苷酸扩增的PCR产物的琼脂糖凝胶电泳图。在每次比较中,扩增程序设置为针对参考引物组C1描述的程序。M:DNA分子量标准。

在使用两种PCR系统检测的更多样本的琼脂糖凝胶中检测到了微弱的条带强度。然而,由于使用简并引物产生的伪影,这些结果未被视为CoV阳性,且无法对低浓度产物进行直接测序(例如,T25和T26样本,面板A;T23样本,面板B)。

测定的部分PRCV和PHEV核苷酸和氨基酸序列显示出细微差异,即使来自同一农场(ST)但来自不同年龄的猪或不同日期采集的标本也是如此(图4)。

**图4** 从匈牙利猪样本中鉴定的猪呼吸道冠状病毒(PRCV,面板A—核苷酸序列;面板B—氨基酸序列)和猪血凝性脑脊髓炎病毒(PHEV,面板C—核苷酸序列;面板D—氨基酸序列)基因组生成的部分RNA依赖性RNA聚合酶核苷酸(nt)和氨基酸(aa)序列的无根邻接系统发育树(用黑圈突出显示)。

**4. 讨论** 已描述冠状病毒数量的爆炸式增长及其对人类和动物健康的重要性,促使人们增加了对这些病毒进行监测的需求。宏基因组学是一种适用于非序列依赖性鉴定和全面调查病毒基因组多样性的工具,但由于成本高昂且处理耗时,对许多实验室来说并非一种便捷且理想的方法。因此,PCR可能是一种更简单且在许多情况下更具特异性的广谱病原体检测选择。当然,在每种情况下,都应考虑研究目标和可用预算后选择工具。

用于诊断特定CoV的最常见方法是基于qPCR扩增S编码的基因组片段,而我们的研究证实,RdRp是广谱PCR检测的最佳靶标。尽管大多数泛-CoV PCR系统适用于监测哺乳动物病毒,但少数系统也能识别禽类冠状病毒,如IBV[27–30]。此处设计的引物组旨在识别变异性较大的禽类冠状病毒,并具有较长的扩增子大小。正向引物靶向CoV RdRp的一个常用保守区域[27,28,30–32],而大多数潜在的反向引物结合位置表现出更高的序列变异性,因此必须仔细选择。Rev1引物被设计用于一个在我们所研究的出版物中尚未使用的位置。发现一个用于非嵌套PCR的引物与Rev2引物位置匹配[30]。为覆盖大多数RdRp序列类型,我们在给定的引物结合位置设计了多于一条简并引物,以应对参考序列中发现的变异性。

用于优化和比较的核酸标准品的选择是一个关键问题。使用DNA标准品(如PCR产物、cDNA、合成DNA和质粒)可能导致RNA病毒的LOD值偏低[27,30,32]。与最常用的DNA模板不同,我们生成了体外转录的RNA来测量LOD,这能更好地代表RNA病毒序列的RT-PCR[28]。一些研究应用了培养的CoV,并根据TCID50、PFU和HA滴度假设灵敏度和LOD[29]。遗憾的是,许多CoV的增殖问题仍未解决,因此可通过这种方式测试的病毒数量有限。此外,重要的是要注意,尽管计算涉及感染性病毒粒子,但PCR会扩增所有靶RNA,包括未衣壳化的分子。

为揭示酶使用的重要性,我们在RNA标准品上测试了三种不同的RT酶与随机和特异性引物,在常规和降落PCR循环程序中的表现。两步法RT酶的效率存在显著差异。更稳健且耐热的SSIV酶结合随机六聚体引发产生了最低的LOD值。此外,降落循环被证明最适合简并广谱引物的退火。与特异性RT引发相比,使用随机六聚体的优势还可用于检测其他RNA病毒的共感染,而无需准备新的RT反应。

由于标准和扩增条件不同,文献中报告的LOD值难以比较。然而,本研究实现的5–50拷贝的LOD和条带稳健性是有前景的。但正如我们的结果所示,选择合适的RT酶并使用RNase抑制剂防止核酸降解极大地影响病毒鉴定的成功率。

为评估其适用性,使用新建立的RT-PCR系统对猪样本进行了CoV监测。PRCV是TGEV的一种变异株,在ORF S中存在缺失,在ORF3序列中存在改变,并伴有点突变[5,33]。新寡核苷酸系统能够检测TGEV,因此其识别PRCV的能力并不意外。由于RdRp序列的相似性,区分TGEV和PRCV几乎是不可能的。此外,总体而言,重组和缺失突变在猪冠状病毒中是频繁事件,因此应进行全基因组测序以鉴定和表征所发现的病毒。所建立的RT-PCR未使用PRCV和PHEV RNA进行测试,但结果表明其适用于至少四种猪CoV的检测。

在匈牙利,先前已发现PEDV、TGEV和PRCV感染[34–38]。TGEV和PRCV在出现体重减轻和脱水的大体病理病变以及组织病理学显示轻度绒毛萎缩的病例中被发现[34]。PEDV于2016年首次在出现腹泻和呕吐的仔猪中鉴定,导致一个自繁自养场的死亡率增加[35]。随后,进一步描述了PEDV毒株,显示与匈牙利邻国斯洛文尼亚的毒株相似[37]。此前未在该国健康动物中进行过广谱冠状病毒筛查。

在本研究中,使用新建立的RT-PCR系统检查了临床健康猪的口腔液和鼻腔样本,以发现所调查猪群中CoV的循环。在所有调查年龄组中均发现了PRCV(PRCV/TGEV)和PHEV,表明这些病毒在这些农场循环而不引发任何疾病。在任何地点均未检测到PHEV。在此类标本中鉴定PRCV和PHEV序列与数据一致,表明这些病毒主要感染呼吸道(PRCV/PHEV)或胃肠道(TGEV)细胞[5]。虽然TGEV是肠道病原体,但PRCV特别与呼吸道疾病相关[5]。然而,本研究未检查粪便标本。

PHEV被归类为属于β冠状病毒属的唯一嗜神经性CoV。在初始感染部位之后,病毒会传播至中枢神经系统。猪的PHEV感染伴随流感样症状、呕吐和消耗性疾病以及脑脊髓炎[39–41]。这些病毒可能对仔猪造成毁灭性影响,但它们通常以亚临床感染形式存在,如本调查中的猪群。

由于在广谱PCR系统中使用简并引物,可能会扩增出伪影以及特异性PCR产物,这些产物在凝胶电泳中分离。所呈现的PCR系统含有高度简并的寡核苷酸,作为一个局限性,意味着这些后果。因此,建议通过测序对此类系统进行验证,以进行特异性病毒鉴定,正如本研究所做的那样。尽管应用了直接测序,但可能扩增了多个模板,需要其他工具进行序列测定,如高通量扩增子测序,我们计划在后续研究中引入。

在RT-PCR和初步序列分析以估计CoV及其宿主谱之后,可尝试进行全基因组测序以精确分类所鉴定的病毒并揭示其序列多样性。新检测系统前景广阔,但其在实地样本中的广泛应用将揭示其真正效用,而非仅使用RNA模板。尽管使用了三个属的某些CoV的基因组序列作为标准品并成功扩增,但我们没有机会用δ冠状病毒测试该PCR。然而,尽管检测了少数代表,但由于CoV的多样性,该系统对其他属成员的有效性仍不清楚。引物组需要不断更新,以确保最广泛地识别病毒序列,这可以通过考虑新描述的病毒序列和未来可用于测试的额外病毒毒株来实现。根据目标,当处理高变异性病原体时,同时使用多于一种应用不同退火位点引物的RT-PCR系统也可能是有利的。

由于遇到的局限性,所呈现的引物不适合诊断目的。然而,通过减少简并位点,经过广泛优化后,这些引物可能被修改以检测亲缘关系更密切的较窄谱CoV。总体而言,广谱RT-PCR提供了广泛筛查CoV的可能性,获得的数据可为进一步研究奠定基础。

**5. 结论** 基于PCR的广谱CoV检测系统的特异性和灵敏度各不相同。此外,它们需要持续审查和适应新描述的冠状病毒。在本研究中,建立了一种适用于鉴定人类和动物冠状病毒的泛-CoV PCR系统。与其他两个系统相比,新引物组表现更好。研究揭示,酶的使用极大地影响了拷贝数的检出限。为某种致病性冠状病毒开发的检测系统因其特异性而更为灵敏。所述检测方法主要适用于研究目的,可有助于评估冠状病毒的宿主谱和多样性。

**补充材料** 以下支持信息可在 https://www.mdpi.com/article/10.3390/ani16030358/s1 下载:文件S1:用于引物设计的引物和冠状病毒RNA依赖性RNA聚合酶序列。

**作者贡献** 概念化,E.F.;方法学,R.V.-K., E.K., B.I., G.B., Á.B. 和 E.F.;验证,D.M. 和 E.K.;调查,D.M., R.V.-K., E.K., H.F.K., B.I., M.D., Á.B. 和 E.F.;资源,T.G., G.K., G.B., Á.B., Z.Z. 和 E.F.;数据管理,E.K.;撰写初稿,D.M., E.K., B.I., G.B., Z.Z. 和 E.F.;撰写审阅与编辑,E.K. 和 E.F.;可视化,D.M. 和 E.F.;监督,E.F.;项目管理,D.M., R.V.-K., B.I. 和 E.F.;经费获取,T.G., G.K., G.B. 和 E.F.。所有作者均已阅读并同意手稿的发表版本。

**机构审查委员会声明** 动物研究方案已获国家食品安全办公室食品安全、动物健康、植物保护与土壤保护部伦理委员会批准(伦理许可号PE/EA/544-5/2018)。

**知情同意声明** 不适用。

**数据可用性声明** 作者确认,支持本研究结果的数据可在文章和补充材料文件S1中获得。部分基因组序列已存入GenBank数据库,登录号为(GenBank登录号PV9488443-PV9488453和PX677392-PX677399)。

**利益冲突** Renáta Varga-Kugler和Ádám Bálint分别是Ceva-Phylaxia有限公司和Vetcontrol有限公司的雇员。然而,他们的工作是在受雇之前独立于上述公司,与匈牙利布达佩斯HUN-REN兽医医学研究所合作完成的。其余作者声明,研究是在没有任何可能被视为潜在利益冲突的商业或财务关系的情况下进行的。

**资助声明** 本研究得到国家研究、发展与创新办公室资助,资助号FK154149和FK137778。进一步支持来自国家研究、发展与创新办公室,项目名称为感染性动物疾病、抗菌素耐药性、兽医公共卫生与食品安全国家实验室,资助号RRF-2.3.1-21-2022-00001。项目号2024-2.1.1-EKÖP-2024-00018在匈牙利文化和创新部的支持下,根据国家研究、发展与创新基金,在2024-2.1.1-EKÖP资助计划下实施。

**脚注** 免责声明/出版商注:所有出版物中包含的陈述、观点和数据仅为作者和贡献者的个人观点,不代表MDPI和/或编辑的观点。MDPI和/或编辑对因内容中的任何想法、方法、指令或产品而对人员或财产造成的任何伤害不承担责任。